GSK1018921
Sponsors
GlaxoSmithKline
Conditions
Schizophrenia
Phase 1
First Time in Human Study With GSK1018921
CompletedNCT00527020
Start: 2007-08-10End: 2008-07-12Updated: 2017-08-04
Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.
CompletedNCT00945503
Start: 2008-05-19End: 2008-12-22Updated: 2017-07-18